www.nytimes.com
3 months agoHealth
Here's the latest on the case.
The Supreme Court is considering restricting access to a commonly used abortion pill, impacting distribution and FDA authority.
The case involves mifepristone, with implications for telemedicine prescriptions and standing of anti-abortion plaintiffs. [ more ]